About Matriks Biotek
Matriks Biotek is a company based in Ankara (Turkey) founded in 2002 by Haluk Ataoglu. Matriks Biotek offers products and services including Shikari® ELISA Kits, CoronaHunter® Products, and Custom ELISA Kits. Matriks Biotek operates in a competitive market with competitors including TGR BioSciences, IBL International, Optofluidic Bioassay, Elisabeth Biosciences and Lifespan Technologies, among others.
- Headquarter Ankara, Turkey
- Founders Haluk Ataoglu
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$7.04 K (USD)-93.9as on Mar 31, 2023
-
Net Profit
-$783.32 (USD)-102.57as on Mar 31, 2023
-
EBITDA
$666.96 (USD)-98.28as on Mar 31, 2023
-
Latest Funding Round
$55.11 K (USD), Grant
Jan 31, 2020
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Matriks Biotek
Matriks Biotek offers a comprehensive portfolio of products and services, including Shikari® ELISA Kits, CoronaHunter® Products, and Custom ELISA Kits.
Kits for accurate monitoring of biological drugs in personalized medicine.
ELISA kits for reliable detection of COVID-19 antibodies.
Tailored kits for testing biosimilar drugs effectively.
Funding Insights of Matriks Biotek
Investors in Matriks Biotek
Matriks Biotek has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Matriks Biotek
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Matriks Biotek
Investment portfolio details for Matriks Biotek
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Matriks Biotek
Detailed financials for Matriks Biotek
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Matriks Biotek Comparisons
Peer comparison for Matriks Biotek
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Matriks Biotek
Matriks Biotek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TGR BioSciences, IBL International, Optofluidic Bioassay, Elisabeth Biosciences and Lifespan Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Specializes in immunoassay technology
|
|
| Locked | Locked | Locked |
Immunoassays and antibodies are supplied for diagnostic applications in labs.
|
|
| Locked | Locked | Locked |
Proprietary microfluidic ELISA plates are provided for bioassays.
|
|
| Locked | Locked | Locked |
Elisabeth Biosciences manufactures and distributes ELISA kits for diagnostic applications.
|
|
| Locked | Locked | Locked |
Develops and sells ELISA kits for detecting carbohydrates in medical diagnostics.
|
Detailed competitors of Matriks Biotek
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Matriks Biotek
Complete news archive for Matriks Biotek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Matriks Biotek
Matriks Biotek was founded in 2002 and raised its 1st funding round 17 years after it was founded.
Matriks Biotek is headquartered in Ankara, Turkey. It is registered at Ankara, Ankara, Turkey.
Haluk Ataoglu is the current CEO of Matriks Biotek. They have also founded this company.
Annual revenue of Matriks Biotek is $7.04K as on Mar 31, 2023.
Founded in 2002 in Ankara, Turkey, the company operates in the biotechnology sector, focusing on diagnostic tools. A range of ELISA kits is provided for tracking biological drugs, including SHIKARI kits and Coronahunter kits for COVID-19 detection. These enzyme immunoassays enable qualitative and quantitative analysis of antibodies against specific drugs and biologics, supporting clinical and research applications.
Matriks Biotek's top competitors include IBL International, TGR BioSciences and Optofluidic Bioassay.
Matriks Biotek offers Shikari® ELISA Kits, CoronaHunter® Products, and Custom ELISA Kits.
Matriks Biotek has 2 investors. Key investors include European Union, and EIC Fund.